BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15998778)

  • 1. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes.
    Cools M; van Aerde K; Kersemaekers AM; Boter M; Drop SL; Wolffenbuttel KP; Steyerberg EW; Oosterhuis JW; Looijenga LH
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5295-303. PubMed ID: 15998778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
    Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor risk in disorders of sex development (DSD).
    Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
    Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
    Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical diagnosis of preinvasive germ cell cancer of the testis.
    SÅ‚owikowska-Hilczer J; Walczak-Jedrzejowska R; Kula K
    Folia Histochem Cytobiol; 2001; 39(2):67-72. PubMed ID: 11374842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor as a novel diagnostic marker for early malignant germ cells.
    Stoop H; Honecker F; van de Geijn GJ; Gillis AJ; Cools MC; de Boer M; Bokemeyer C; Wolffenbuttel KP; Drop SL; de Krijger RR; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis JW; Looijenga LH
    J Pathol; 2008 Sep; 216(1):43-54. PubMed ID: 18566970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of RBM expression as a marker for carcinoma in situ of prepubertal dysgenetic testis.
    Schreiber L; Lifschitz-Mercer B; Paz G; Yavetz H; Zadik Z; Kula K; Slowikowska-Hilczer J; Rey R; Elliott DJ; Maymon BB
    J Androl; 2003; 24(1):78-84. PubMed ID: 12514087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.
    Honecker F; Stoop H; de Krijger RR; Chris Lau YF; Bokemeyer C; Looijenga LH
    J Pathol; 2004 Jul; 203(3):849-57. PubMed ID: 15221945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
    Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
    Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
    Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated gonadal tissue, Y chromosome instability, and tumors in XY gonadal dysgenesis.
    Beaulieu Bergeron M; Lemieux N; Brochu P
    Pediatr Dev Pathol; 2011; 14(6):445-59. PubMed ID: 21692598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of germ cell malignancy in children with XY intersex versus isolated cryptorchidism by immunohistochemistry.
    Law H; Mushtaq I; Williams S; Malone M; Sebire NJ
    Fetal Pediatr Pathol; 2006; 25(2):95-105. PubMed ID: 16908459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.
    Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cell-processing method 'AgarCytos' in conjunction with OCT3/4 and PLAP to detect intratubular germ cell neoplasia in non-obstructive azoospermia using remnants of testicular sperm extraction specimens.
    Hessel M; Ramos L; Hulsbergen AF; D'Hauwers KW; Braat DD; Hulsbergen-van de Kaa CA
    Hum Reprod; 2013 Oct; 28(10):2608-20. PubMed ID: 23900208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.
    Iczkowski KA; Butler SL; Shanks JH; Hossain D; Schall A; Meiers I; Zhou M; Torkko KC; Kim SJ; MacLennan GT
    Hum Pathol; 2008 Feb; 39(2):275-81. PubMed ID: 18045648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does intratubular germ cell neoplasia, unclassified type exist in prepubertal, cryptorchid testes?
    Fan R; Ulbright TM
    Fetal Pediatr Pathol; 2012 Feb; 31(1):21-4. PubMed ID: 22026641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular development in the complete androgen insensitivity syndrome.
    Hannema SE; Scott IS; Rajpert-De Meyts E; Skakkebaek NE; Coleman N; Hughes IA
    J Pathol; 2006 Mar; 208(4):518-27. PubMed ID: 16400621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory.
    van Casteren NJ; de Jong J; Stoop H; Steyerberg EW; de Bekker-Grob EW; Dohle GR; Oosterhuis JW; Looijenga LH
    Int J Androl; 2009 Dec; 32(6):666-74. PubMed ID: 18798762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.